Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001387131-11-002684
Filing Date
2011-11-22
Accepted
2011-11-22 13:29:55
Documents
6
Period of Report
2011-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDED CURRENT REPORT therapeu_8ka-100411.htm 8-K/A 787395
2 NOTE ex-10_5.htm EX-10.5 36382
3 SECURITY AGREEMENT ex-10_6.htm EX-10.6 65403
4 NOTE ex-10_9.htm EX-10.9 35725
5 graphic1.jpg GRAPHIC 11346
6 graphic2.jpg GRAPHIC 12958
  Complete submission text file 0001387131-11-002684.txt   960400
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 516-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-16731 | Film No.: 111221341
SIC: 2834 Pharmaceutical Preparations